thinking the future
We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community
Our Products
are mainly addressed to be used in Hematologic, Oncologic, Urologic and Special Treatments as well as Rare Diseases
News
Bioprofarma Bagó Announces In-Licensing Exclusive Partnership with Polaris Pharmaceuticals to introduce ADI-PEG20
Buenos Aires, Argentina – Bioprofarma Bagó (a fully owned subsidiary of GRUPO EMPRESARIAL BAGO), today announced an exclusive licensing agreement... Read more
New release LIPECELTE® trabectedin
Introducing LIPECELTE® Trabectedin: A New Addition to Our Oncology Line At Bioprofarma Bagó, we reaffirm our dedication to patient care with the launch of... Read more
FUCDIM Uro-Oncology Conference
Bioprofarma Bagó was present on October 24th and 25th at the Uro-Oncology Conference: Controversies and New Developments 2024, organized by... Read more
Bioprofarma Bagó worldwide
